» Articles » PMID: 10701085

Dapsone: Unapproved Uses or Indications

Overview
Journal Clin Dermatol
Publisher Elsevier
Specialty Dermatology
Date 2000 Mar 4
PMID 10701085
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

Alpha-Lipoic Acid and Its Enantiomers Prevent Methemoglobin Formation and DNA Damage Induced by Dapsone Hydroxylamine: Molecular Mechanism and Antioxidant Action.

Espindola K, Varela E, de Albuquerque R, Figueiredo R, Santos S, Malcher N Int J Mol Sci. 2023; 24(1).

PMID: 36613503 PMC: 9820452. DOI: 10.3390/ijms24010057.


A comprehensive insight into the anti-inflammatory properties of dapsone.

Khalilzadeh M, Shayan M, Jourian S, Rahimi M, Sheibani M, Dehpour A Naunyn Schmiedebergs Arch Pharmacol. 2022; 395(12):1509-1523.

PMID: 36125533 DOI: 10.1007/s00210-022-02297-1.


Development of Novel Chitosan Microcapsules for Pulmonary Delivery of Dapsone: Characterization, Aerosol Performance, and In Vivo Toxicity Evaluation.

Ortiz M, Jornada D, Pohlmann A, Guterres S AAPS PharmSciTech. 2015; 16(5):1033-40.

PMID: 25652730 PMC: 4674640. DOI: 10.1208/s12249-015-0283-3.


Dapsone in dermatology and beyond.

Wozel G, Blasum C Arch Dermatol Res. 2013; 306(2):103-24.

PMID: 24310318 PMC: 3927068. DOI: 10.1007/s00403-013-1409-7.


Indomethacin-related leukocytoclastic vasculitis: a case report and review of literature.

Hussain N, Mustafa U, Davis J, Thakkar S, Ali A, Mirrakhimov A Case Rep Dermatol. 2013; 5(1):33-7.

PMID: 23525826 PMC: 3604871. DOI: 10.1159/000348240.